ESC Premium Access

Clinical effectiveness of primary prevention implantable defibrillators: results of the EU-CERT-ICD non-randomised, controlled, multicentre study

Topic: Implantable Cardioverter-Defibrillator (ICD)

Congress Presentation

About the speaker

Associate Professor Markus Zabel

University Medical Centre of Gottingen (UMG), Goettingen (Germany)
4 presentations
0 follower

4 more presentations in this session

Spironolactone in atrial fibrillation with preserved cardiac contractility

Speaker: Doctor E. Shantsila (Liverpool, GB)


Effects of Sacubitril-Valsartan Compared with Enalapril on Arterial Hemodynamics and Cardiac Remodeling in Patients with Heart Failure and Reduced Ejection Fraction

Speaker: Doctor A. Desai (Boston, US)


Effects of Angiotensin Receptor/Neprilysin Inhibitor Therapy on NT-proBNP and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction: Primary Results of the PROVE-HF Study

Speaker: Professor J. Januzzi (Boston, US)


Clinical phenotypes, gender differences and adverse events associated with truncating variants in the Titin (TTN) gene

Speaker: Doctor M. Akhtar (London, GB)


Access the full session

Late Breaking Science in Heart Failure 1

Speakers: Associate Professor M. Zabel, Doctor E. Shantsila, Doctor A. Desai, Professor J. Januzzi, Doctor M. Akhtar

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb